Medipal Holdings Corporation · TSE:7459
Medipal — Q1 FY2025 Earnings Presentation
14 slides from Medipal's earnings presentation, Aug 5, 2025
Slide 1: Financial Results for the First Quarter Ended Jun. 30, 2025
August. 5, 2025 Financial Results for the First Quarter Ended Jun. 30, 2025 Expand, Support, and Connect “Pharmaceuticals, Health, and Beauty” an Orchestra in Support of People's Health The MEDIPAL Group aims to realize a society in which everyone can live with physical and mental well-being and to
Slide 2: Overview of Financial Results for 1Q/FY2025
Overview of Financial Results for 1Q/FY2025 Core businesses performing steadily, with a start in line with the forecast Focusing on strategic investments to ensure sustainable growth. Net sales increased by 3.9% due to higher YoY sales in all business segments Operating profit increased by 5.8%
Slide 3: 1Q/FY2025 Consolidated Statements
1Q/FY2025 Consolidated Statements (¥ billion) 1Q/FY2024 1Q/FY2025 Results Results YoY （% of Net Sales） （% of Net Sales） YoY Change % of Change Net Sales 909.3 945.1 +35.8 +3.9% Gross Profit 62.5 64.6 +2.0 +3.3% [6.88％] [6.84％] [(0.04pp)] SG&A Expenses 49.3 50.6 +1.3 +2.7% [5.42%] [5.36％] [(0.07pp)]
Slide 4: 1Q/FY2025 Consolidated Results [YoY Change]
1Q/FY2025 Consolidated Results [YoY Change] All business segments performed steadily, resalting in increased profits with increased sales absorbing increased SG&A expenses Increased the adjusted operating profit excluding the impact of growth investment-related expenses Amount YoY Change Change fact
Slide 5: Factors behind YoY changes in Gross Profit, Operating Profit and Ordinary Profit
Factors behind YoY changes in Gross Profit, Operating Profit and Ordinary Profit (¥ billion) +0.7 SG＆A expenses（Increase） Non-Operating Income/Expenses Profit from MEDICEO (1.3) +0.5 +1.3 Profit from PALTAC +2.0 (0.2) (1.1) SG＆A expenses of MEDICEO +0.6 (0.1) +1.3 Full acquisition of PreMedica Inc.
Slide 6: Factors behind YoY changes in Ordinary Profit, Profit before Income Taxes and Profit attributable to Owners of Parent
Factors behind YoY changes in Ordinary Profit ,Profit before Income Taxes and Profit attributable to Owners of Parent (¥ billion) Extraordinary Income/Expenses (0.0) +0.4 (0.9) +0.4 +1.3 Insurance proceeds for +0.0 +1.2 damage to buildings (0.6) caused by the Noto earthquake Gain on sale Business re
Slide 7: 1Q/FY2025 MEDICEO Business
1Q/FY2025 MEDICEO Business (¥ billion) 1Q/FY2024 1Q/FY2025 Results Results YoY （% of Net Sales） （% of Net Sales） YoY Change % of Change Net Sales 577.8 600.0 +22.1 +3.8% Gross Profit 36.0 36.7 +0.7 +2.0% [6.24%] [6.13%] [(0.11pp)] SG&A Expenses 31.0 31.2 +0.2 +0.7% [5.37%] [5.21%] [(0.16pp)] SG&A Ex
Slide 8: 1Q/FY2025 MEDICEO Business [YoY Change]
1Q/FY2025 MEDICEO Business [YoY Change] "The two As (ALC and AR*)" led to exceeding the market growth by expanding sales through a focus on growth products and dispensing pharmacies channel. Operating profit increased as the decline in gross profit margin due to changes in product mix offset by incr
Slide 9: 1Q/FY2025 PALTAC Business
1Q/FY2025 PALTAC Business (¥ billion) 1Q/FY2024 1Q/FY2025 Results Results YoY （% of Net Sales） （% of Net Sales） YoY Change % of Change Net Sales 302.9 316.0 +13.1 +4.3% 22.3 23.6 +1.3 +6.0% Gross Profit [7.38%] [7.49%] [+0.12pp] SG&A 14.9 16.0 +1.1 +7.7% Expenses [4.93%] [5.08%] [+0.16pp] Operating
Slide 10: 1Q/FY2025 PALTAC Business [YoY Change]
1Q/FY2025 PALTAC Business [YoY Change] Achieved increased revenue and profits, despite the impact of cost-consciousness due to rising prices • Net sales increased due to successful efforts to acquire new accounts and expanding the range of new high-value-added products, despite the trend of thrifty
Slide 11: 1Q/FY2025 AGRO・FOOD Business
1Q/FY2025 AGRO・FOOD Business (¥ billion) 1Q/FY2024 1Q/FY2025 Results Results YoY （% of Net Sales） （% of Net Sales） YoY Change % of Change Net Sales 29.5 30.1 +0.5 +1.9％ Gross Profit 4.1 4.2 +0.0 +0.5% [14.21%] [14.02%] [(0.20pp)] SG&A Expenses 3.5 3.4 (0.0) (1.7%) [11.90%] [11.47%] [(0.４２pp)] SG&A E
Slide 12: 1Q/FY2025 AGRO・FOOD Business [YoY Change]
1Q/FY2025 AGRO・FOOD Business [YoY Change] Both Animal Health Products Wholesale Business and Food Processing Raw Materials Wholesale and Related Business remained steady Achieved increased revenue and profits, despite being affected by rising costs due to the weak yen, etc. Amount YoY Change Change
Slide 13: Management Philosophy
Management Philosophy Contributing to peopleʼs health and the advancement of society through creation of value in distribution Copyright © 2025 MEDIPAL HOLDINGS CORPORATION, All rights reserved. 13
Slide 14: Forward-Looking Statements
【Forward-Looking Statements】 These materials reflect analysis of available information and various trends as of the date on the cover. Risks and uncertainties affecting the Companyʼs business could cause actual results to differ materially from any projections presented in these materials. In the ev